Shares of McKesson Co. (NYSE:MCK) have been given a consensus rating of “Hold” by the twenty analysts that are covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, eight have assigned a hold recommendation and nine have given a buy recommendation to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $177.22.
Several equities analysts have commented on MCK shares. Deutsche Bank started coverage on McKesson in a research report on Monday, December 4th. They issued a “buy” rating and a $175.00 target price for the company. Zacks Investment Research upgraded McKesson from a “hold” rating to a “buy” rating and set a $177.00 target price for the company in a research report on Tuesday, December 26th. ValuEngine downgraded McKesson from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Evercore ISI began coverage on McKesson in a research report on Thursday, January 4th. They set an “outperform” rating and a $179.00 price objective for the company. Finally, Robert W. Baird restated a “buy” rating and set a $200.00 price objective on shares of McKesson in a research report on Wednesday, January 17th.
McKesson (NYSE MCK) traded down $0.74 during trading on Friday, reaching $153.22. The company’s stock had a trading volume of 985,179 shares, compared to its average volume of 1,726,208. The company has a quick ratio of 0.61, a current ratio of 1.07 and a debt-to-equity ratio of 0.63. The company has a market capitalization of $31,770.00, a P/E ratio of 7.37, a PEG ratio of 1.47 and a beta of 1.29. McKesson has a 1 year low of $133.82 and a 1 year high of $178.86.
McKesson (NYSE:MCK) last posted its earnings results on Thursday, February 1st. The company reported $3.41 EPS for the quarter, beating the consensus estimate of $2.92 by $0.49. The firm had revenue of $53.62 billion during the quarter, compared to the consensus estimate of $51.98 billion. McKesson had a return on equity of 22.98% and a net margin of 2.34%. The business’s quarterly revenue was up 7.0% on a year-over-year basis. During the same period last year, the company earned $3.04 earnings per share. equities research analysts forecast that McKesson will post 12.71 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, April 2nd. Investors of record on Thursday, March 1st will be paid a dividend of $0.34 per share. The ex-dividend date is Wednesday, February 28th. This represents a $1.36 annualized dividend and a yield of 0.89%. McKesson’s dividend payout ratio is currently 6.54%.
In related news, SVP Erin M. Lampert sold 1,413 shares of the firm’s stock in a transaction that occurred on Thursday, March 1st. The stock was sold at an average price of $149.38, for a total transaction of $211,073.94. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.20% of the company’s stock.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Icon Wealth Partners LLC acquired a new stake in McKesson during the fourth quarter worth approximately $111,000. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC boosted its position in shares of McKesson by 176.6% during the fourth quarter. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC now owns 769 shares of the company’s stock valued at $130,000 after buying an additional 491 shares during the last quarter. Hikari Tsushin Inc. purchased a new position in shares of McKesson during the fourth quarter valued at approximately $151,000. Wealthcare Advisory Partners LLC purchased a new position in shares of McKesson during the third quarter valued at approximately $155,000. Finally, Virtue Capital Management LLC purchased a new position in shares of McKesson during the fourth quarter valued at approximately $180,000. 88.91% of the stock is owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY WARNING: This article was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this article on another site, it was illegally copied and reposted in violation of U.S. & international copyright & trademark laws. The original version of this article can be viewed at https://www.dispatchtribunal.com/2018/04/08/mckesson-co-mck-given-average-rating-of-hold-by-analysts.html.
McKesson Company Profile
McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.